Name: Equity Multiplier

Definition: The equity multiplier shows how much total assets the company controls for every dollar invested by shareholders. It reflects how much debt is being used to stretch owners’ equity. A higher multiplier means greater use of debt to amplify returns — but also amplifies risk if things go wrong. Lower multipliers suggest a safer, more self-funded business.

Interpretation:
• In '2021', OABI's equity multiplier was 1.30, representing the level of financial leverage utilized. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2021' stood at 1.41.
• In '2022', OABI's equity multiplier was 1.23, representing the level of financial leverage utilized. The decrease since '2021' reflects improving financial health. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2022' stood at 1.65. Industry average increased by 0.24 compared to previous year.
• In '2023', OABI's equity multiplier was 1.19, representing the level of financial leverage utilized. The decrease since '2022' reflects improving financial health. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2023' stood at 1.76. Industry average increased by 0.11 compared to previous year.
• In '2024', OABI's equity multiplier was 1.13, representing the level of financial leverage utilized. The decrease since '2023' reflects improving financial health. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2024' stood at 2.08. Industry average increased by 0.32 compared to previous year.
Overall, OABI's equity multiplier has consistently declined during the past 4 years.

Formula: Equity Multiplier = Total Assets / Shareholders' Equity

Good Range: Usually ranges from 1.5 to 3 depending on industry.